secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDICINOVA INC (MNOV)
CIK:        0001226616
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001193125-23-204956
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MediciNova appoints Nicole Lemerond to Board, filling vacancy
-------------------------------------------------------------

- Lemerond appointed as Class I director, term expiring at 2026 Annual Meeting.
- She joins Audit, Compensation, and Nominating Committees immediately.
- Granted option to purchase 18,333 shares vesting quarterly through June 30, 2024.
- Lemerond is former Managing Partner of NV Capital (2010-2022) with 25+ years in healthcare finance.
- No family relationships or material transactions with existing directors or officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1226616/000119312523204956/0001193125-23-204956-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1226616/000119312523204956/d533741d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-204956

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer